To determine the risk factors of hyperlactatemia in pulmonary endarterectomy (PEA) surgery and assess whether elevated blood lactate levels are associated with adverse outcomes.
Methods
In this retrospective observational study, a total of 111 consecutive patients who underwent PEA for chronic thromboembolic pulmonary hypertension at the XXX Hospital between December 2016 and January 2022 were included. We retrospectively evaluated arterial blood samples analyzed intraoperatively. The pre- and intraoperative risk factors for hyperlactatemia and the postoperative outcomes were recorded.
Results
Lactate levels gradually increased during surgery. The optimal cut-off lactate level for major postoperative complications, calculated using receiver operating characteristic analysis, was 7.0 mmol/L. Deep hypothermic circulatory arrest (DHCA) duration, nadir hematocrit, and preoperative pulmonary vascular resistance were risk factors for lactate levels >7 mmol/L. Moreover, the intraoperative peak lactate level during PEA under DHCA was found to be a statistically significant predictor of major complications being associated with longer mechanical ventilation time (r = 0.294; p = .003) and intensive care unit length of stay (r = 0.327; p = .001).
Conclusions
Deep hypothermic circulatory arrest duration, nadir hematocrit, and preoperative pulmonary vascular resistance were associated with hyperlactatemia. Increased lactate levels were independent predictors of longer mechanical ventilation time, intensive care unit length of stay, and major complications.
JenkinsDMadaniMFadelE, et al.Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev2017; 26: 160111.
4.
VuylstekeASharplesLCharmanG, et al.Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial. Lancet2011; 378: 1379–1387.
5.
DemersPElkouriSMartineauR, et al.Outcome with high blood lactate levels during cardiopulmonary bypass in adult cardiac operation. Ann Thorac Surg2000; 70: 2082–2086.
6.
LindsayAJXuMSesslerDI, et al.Lactate clearance time and concentration linked to morbidity and death in cardiac surgical patients. Ann Thorac Surg2013; 95: 486–492.
7.
RanucciMDe ToffolBIsgròG, et al.Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome. Crit Care2006; 10: R167.
8.
MadaniMMAugerWRPretoriusV, et al.Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg2012; 94: 97–103.
9.
AndersenLW. Lactate elevation during and after major cardiac surgery in adults: a review of etiology, prognostic value, and management. Anesth Analg2017; 125: 743–752.
10.
RaperRFCameronGWalkerD, et al.Type B lactic acidosis following cardiopulmonary bypass. Crit Care Med1997; 25: 46–51.
11.
InoueSKuroMFuruyaH. What factors are associated with hyperlactatemia after cardiac surgery characterized by well-maintained oxygen delivery and a normal postoperative course? A retrospective study. Eur J Anaesthesiol2001; 18: 576–584.
12.
EvansASLevinMALinHM, et al.Prognostic value of hyperlactatemia and lactate clearance after mitral valve surgery. J Cardiothorac Vasc Anesth2018; 32: 636–643.
13.
BennettJMWiseESHockingKM, et al.Hyperlactemia predicts surgical mortality in patients presenting with acute Stanford Type-A aortic dissection. J Cardiothorac Vasc Anesth2017; 31: 54–60.
14.
McCulloughJNZhangNReichDL, et al.Cerebral metabolic suppression during hypothermic circulatory arrest in humans. Ann Thorac Surg1999; 67: 1895–1899.
15.
YanTDBannonPGBavariaJ, et al.Consensus on hypothermia in aortic arch surgery. Ann Cardiothorac Surg2013; 2: 163–168.
16.
HuybregtsRAde VroegeRJansenEK, et al.The association of hemodilution and transfusion of red blood cells with biochemical markers of splanchnic and renal injury during cardiopulmonary bypass. Anesth Analg2009; 109: 331–339.
17.
RanucciMCarboniGCotzaM, et al.Hemodilution on cardiopulmonary bypass as a determinant of early postoperative hyperlactatemia. PLoS One2015; 10: e0126939.
18.
von HeymannCSanderMFoerA, et al.The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for elective low risk coronary artery bypass graft surgery on oxygen delivery and clinical outcome--a randomized controlled study [ISRCTN35655335]. Crit Care2006; 10: R58.
19.
ThistlethwaitePAMoMMadaniMM, et al.Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg2002; 124: 1203–1211.
20.
MailletJMLe BesneraisPCantoniM, et al.Frequency, risk factors, and outcome of hyperlactatemia after cardiac surgery. Chest2003; 123: 1361–1366.
21.
O’ConnorEFraserJF. The interpretation of perioperative lactate abnormalities in patients undergoing cardiac surgery. Anaesth Intensive Care2012; 40: 598–603.
22.
HauerDKilgerEKaufmannI, et al.Risk and outcome analysis of renal replacement therapies in patients after cardiac surgery with pre-operatively normal renal function. Anaesthesia2009; 64: 615–619.
23.
Lopez-DelgadoJCEsteveFTorradoH, et al.Influence of acute kidney injury on short- and long-term outcomes in patients undergoing cardiac surgery: risk factors and prognostic value of a modified RIFLE classification. Crit Care2013; 17: R293.
24.
Jorge-MonjasPBustamante-MunguiraJLorenzoM, et al.Predicting cardiac surgery-associated acute kidney injury: the CRATE score. J Crit Care2016; 31: 130–138.
25.
NicoliniFMaestriFFragnitoC, et al.Early neurological injury after cardiac surgery: insights from a single centre prospective study. Acta Biomed2013; 84: 44–52.
26.
GasparovicHBurcarIKopjarT, et al.NT-pro-BNP, but not C-reactive protein, is predictive of atrial fibrillation in patients undergoing coronary artery bypass surgery. Eur J Cardio Thorac Surg2010; 37: 100–105.
27.
RanucciMBaryshnikovaESimeoneF, et al.Moderate-degree acidosis is an independent determinant of postoperative bleeding in cardiac surgery. Minerva Anestesiol2015; 81: 885–893.
28.
RaoVIvanovJWeiselRD, et al.Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery. Ann Thorac Surg2001; 71: 1925–1930.
29.
SavareseGPaolilloSCostanzoP, et al.Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials. J Am Coll Cardiol2012; 60: 1192–1201.
30.
GablerNBFrenchBStromBL, et al.Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials. Circulation2012; 126: 349–356.
31.
GovenderPToshWBurtC, et al.Evaluation of increase in intraoperative lactate level as a predictor of outcome in adults after cardiac surgery. J Cardiothorac Vasc Anesth2020; 34: 877–884.
32.
MatteucciMFerrareseSCantoreC, et al.Hyperlactatemia during cardiopulmonary bypass: risk factors and impact on surgical results with a focus on the long-term outcome. Perfusion2020; 35: 756–762.
33.
ToramanFEvrenkayaSYuceM, et al.Lactic acidosis after cardiac surgery is associated with adverse outcome. Heart Surg Forum2004; 7: E155–E159.
34.
Lopez-DelgadoJCEsteveFJavierreC, et al.Evaluation of serial arterial lactate levels as a predictor of hospital and long-term mortality in patients after cardiac surgery. J Cardiothorac Vasc Anesth2015; 29: 1441–1453.
35.
AndersenLWHolmbergMJDohertyM, et al.Postoperative lactate levels and hospital length of stay after cardiac surgery. J Cardiothorac Vasc Anesth2015; 29: 1454–1460.
36.
HajjarLAAlmeidaJPFukushimaJT, et al.High lactate levels are predictors of major complications after cardiac surgery. J Thorac Cardiovasc Surg2013; 146: 455–460.
